NYSEAMERICAN : NNVC
NanoViricides, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.33 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 33.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 3.60M | 3.60M | 4.04M | 3.08M | 2.55M | 2.33M |
| Research & Development | 4.71M | 4.71M | 5.55M | 5.44M | 6.39M | 5.78M |
| Operating Expenses | 8.31M | 8.31M | 9.59M | 8.52M | 8.94M | 8.11M |
| Operating Income | -8.31M | -8.31M | -9.59M | -8.52M | -8.94M | -8.11M |
| Interest Expense | -149.00 | -49.81K | -938.00 | -5.12K | ||
| Interest & Investment Income | 87.85K | 87.85K | 124.83K | 271.77K | 355.83K | 11.86K |
| EBT Excluding Unusual Items | -8.22M | -8.22M | -9.47M | -8.29M | -8.59M | -8.11M |
| Pretax Income | -8.22M | -8.22M | -9.47M | -8.29M | -8.59M | -8.11M |
| Net Income | -8.22M | -8.22M | -9.47M | -8.29M | -8.59M | -8.11M |
| Net Income to Common | -8.22M | -8.22M | -9.47M | -8.29M | -8.59M | -8.11M |
| Shares Outstanding (Basic) | 20.19M | 20.19M | 15.12M | 11.87M | 11.63M | 11.53M |
| Shares Outstanding (Diluted) | 20.19M | 20.19M | 15.12M | 11.87M | 11.63M | 11.53M |
| EPS (Basic) | -0.41 | -0.41 | -0.63 | -0.70 | -0.74 | -0.70 |
| EPS (Diluted) | -0.41 | -0.41 | -0.63 | -0.70 | -0.74 | -0.70 |
| Free Cash Flow | -7.78M | -7.78M | -8.54M | -6.47M | -5.82M | -6.22M |
| Free Cash Flow Per Share | -0.39 | -0.39 | -0.56 | -0.55 | -0.50 | -0.54 |
| EBITDA | -7.78M | -7.78M | -8.85M | -7.76M | -8.20M | -7.39M |
| D&A For EBITDA | 525.29K | 525.29K | 743.80K | 759.01K | 747.53K | 723.33K |
| EBIT | -8.31M | -8.31M | -9.59M | -8.52M | -8.94M | -8.11M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.79M | 2.79M | 1.56M | 4.80M | 8.15M | 14.07M |
| Cash & Short-Term Investments | 2.79M | 2.79M | 1.56M | 4.80M | 8.15M | 14.07M |
| Prepaid Expenses | 368.51K | 368.51K | 112.15K | 172.74K | 295.49K | 350.02K |
| Total Current Assets | 3.16M | 3.16M | 1.67M | 4.97M | 8.45M | 14.42M |
| Property, Plant & Equipment | 6.40M | 6.40M | 6.83M | 7.51M | 8.11M | 8.69M |
| Other Intangible Assets | 308.77K | 308.77K | 317.04K | 325.31K | 333.58K | 341.85K |
| Other Long-Term Assets | 1.03K | 1.03K | 2.44K | 14.56K | 14.36K | 42.44K |
| Total Assets | 9.87M | 9.87M | 8.82M | 12.82M | 16.90M | 23.49M |
| Accounts Payable | 323.82K | 323.82K | 459.09K | 376.27K | 157.06K | 57.96K |
| Accrued Expenses | 38.33K | 38.33K | 25.97K | 262.47K | 143.76K | 45.69K |
| Short-Term Debt | 94.79K | |||||
| Other Current Liabilities | 828.58K | 828.58K | 821.46K | 720.04K | 233.43K | 214.40K |
| Total Current Liabilities | 1.19M | 1.19M | 1.31M | 1.36M | 534.25K | 412.84K |
| Other Long-Term Liabilities | 1.50M | |||||
| Total Liabilities | 1.19M | 1.19M | 1.31M | 1.36M | 2.03M | 412.84K |
| Common Stock | 230.00 | 230.00 | 166.00 | 131.00 | 117.00 | 116.00 |
| Additional Paid-In Capital | 165.74M | 165.74M | 156.36M | 150.84M | 145.95M | 145.57M |
| Retained Earnings | -157.06M | -157.06M | -148.84M | -139.37M | -131.08M | -122.49M |
| Total Common Equity | 8.68M | 8.68M | 7.52M | 11.46M | 14.87M | 23.08M |
| Shareholders' Equity | 8.68M | 8.68M | 7.52M | 11.46M | 14.87M | 23.08M |
| Total Liabilities & Equity | 9.87M | 9.87M | 8.82M | 12.82M | 16.90M | 23.49M |
| Total Debt | 94.79K | |||||
| Net Cash (Debt) | 2.79M | 2.79M | 1.56M | 4.80M | 8.15M | 13.97M |
| Net Cash Per Share | 0.14 | 0.14 | 0.10 | 0.40 | 0.70 | 1.21 |
| Filing Date Shares Outstanding | 25.52M | 25.52M | 17.43M | 14.68M | 11.75M | 11.59M |
| Total Common Shares Outstanding | 23.01M | 23.01M | 16.61M | 13.14M | 11.70M | 11.59M |
| Working Capital | 1.97M | 1.97M | 364.19K | 3.61M | 7.91M | 14.00M |
| Book Value Per Share | 0.38 | 0.38 | 0.45 | 0.87 | 1.27 | 1.99 |
| Tangible Book Value | 8.37M | 8.37M | 7.20M | 11.14M | 14.53M | 22.74M |
| Tangible Book Value Per Share | 0.36 | 0.36 | 0.43 | 0.85 | 1.24 | 1.96 |
| Land | 260.00K | 260.00K | 260.00K | 260.00K | 260.00K | 260.00K |
| Machinery | 6.20M | 6.20M | 6.60M | 6.54M | 6.38M | 6.25M |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -8.22M | -8.22M | -9.47M | -8.29M | -8.59M | -8.11M |
| Depreciation & Amortization | 525.29K | 525.29K | 743.80K | 759.01K | 747.53K | 723.33K |
| Stock-Based Compensation | 367.95K | 367.95K | 224.03K | 222.75K | 215.19K | 342.63K |
| Other Operating Activities | 156.99K | 935.09K | ||||
| Change in Accounts Payable | -128.16K | -128.16K | 184.24K | 705.82K | 118.13K | 40.80K |
| Change in Other Net Operating Assets | -242.59K | -242.59K | -163.78K | 291.06K | 1.68M | 173.76K |
| Operating Cash Flow | -7.70M | -7.70M | -8.48M | -6.32M | -5.67M | -5.89M |
| Capital Expenditures | -84.32K | -84.32K | -56.96K | -156.56K | -151.71K | -324.35K |
| Investing Cash Flow | -84.32K | -84.32K | -56.96K | -156.56K | -151.71K | -324.35K |
| Short-Term Debt Repaid | -94.79K | -234.72K | ||||
| Total Debt Repaid | -94.79K | -234.72K | ||||
| Net Debt Issued (Repaid) | -94.79K | -234.72K | ||||
| Issuance of Common Stock | 9.02M | 9.02M | 5.30M | 3.12M | ||
| Financing Cash Flow | 9.02M | 9.02M | 5.30M | 3.12M | -94.79K | -234.72K |
| Net Cash Flow | 1.24M | 1.24M | -3.24M | -3.35M | -5.92M | -6.45M |
| Free Cash Flow | -7.78M | -7.78M | -8.54M | -6.47M | -5.82M | -6.22M |
| Free Cash Flow Per Share | -0.39 | -0.39 | -0.56 | -0.55 | -0.50 | -0.54 |
| Levered Free Cash Flow | -4.75M | -4.75M | -5.08M | -3.58M | -4.51M | -4.31M |
| Unlevered Free Cash Flow | -4.75M | -4.75M | -5.08M | -3.55M | -4.51M | -4.31M |
| Cash Interest Paid | 149.00 | 938.00 | 5.12K | |||
| Change in Working Capital | -370.75K | -370.75K | 20.46K | 996.88K | 1.80M | 214.56K |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 33.95M | 31.44M | 22.50M | 20.32M | 13.42M | 21.72M |
| Enterprise Value | 31.15M | 28.22M | 19.96M | 17.06M | 3.77M | 6.31M |
| Last Close Price | 1.33 | 1.38 | 1.40 | 1.72 | 1.15 | 1.88 |
| PB Ratio | 3.52 | 3.62 | 2.99 | 1.77 | 0.90 | 0.94 |
| P/TBV Ratio | 4.05 | 3.75 | 3.12 | 1.82 | 0.92 | 0.95 |
| Debt / Equity Ratio | 0.00 | |||||
| Net Debt / Equity Ratio | -0.32 | -0.32 | -0.21 | -0.42 | -0.55 | -0.60 |
| Net Debt / EBITDA Ratio | 0.36 | 0.36 | 0.18 | 0.62 | 0.99 | 1.89 |
| Net Debt / FCF Ratio | 0.36 | 0.36 | 0.18 | 0.74 | 1.40 | 2.25 |
| Quick Ratio | 2.35 | 2.35 | 1.19 | 3.53 | 15.26 | 34.07 |
| Current Ratio | 2.66 | 2.66 | 1.28 | 3.66 | 15.81 | 34.92 |
| Return on Equity (ROE) | -101.46% | -101.46% | -99.75% | -63.00% | -45.27% | -30.60% |
| Return on Assets (ROA) | -55.53% | -55.53% | -55.39% | -35.82% | -27.68% | -18.87% |
| Return on Capital Employed (ROCE) | -95.70% | -95.70% | -127.60% | -74.30% | -54.60% | -35.20% |
| Earnings Yield | -30.61% | -26.14% | -42.07% | -40.82% | -64.02% | -37.32% |
| FCF Yield | -22.92% | -24.75% | -37.94% | -31.85% | -43.39% | -28.62% |
| Buyback Yield / Dilution | -33.55% | -33.55% | -27.34% | -2.11% | -0.79% | -5.81% |